Journal article · 2025

The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases

Huji Xu

Nature Reviews Rheumatology, 22(2), 78–79 · Published 10 December 2025 · DOI 10.1038/s41584-025-01343-5

View at the publisherCite this paper

In brief

“The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases” is a 2025 journal article by Huji Xu, published in Nature Reviews Rheumatology. OpenAlex counts 6 citations as of 20 November 2026, which puts it in the top 3% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
6
Most cited in
2026 (6)
Field-weighted impact
1.63
References
9
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Xu, H. (2025). The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases. Nature Reviews Rheumatology, 22(2), 78–79. https://doi.org/10.1038/s41584-025-01343-5

MLA 9

Xu, Huji. “The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases.” Nature Reviews Rheumatology, vol. 22, no. 2, 2025, pp. 78–79. https://doi.org/10.1038/s41584-025-01343-5.

Chicago

Xu, Huji. 2025. “The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases.” Nature Reviews Rheumatology 22 (2): 78–79. https://doi.org/10.1038/s41584-025-01343-5.

Harvard

Xu, H. (2025) ‘The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases’, Nature Reviews Rheumatology, 22(2), pp. 78–79. doi:10.1038/s41584-025-01343-5.

IEEE

H. Xu, “The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases,” Nature Reviews Rheumatology, vol. 22, no. 2, pp. 78–79, 2025, doi: 10.1038/s41584-025-01343-5.

BibTeX

@article{xu2025dawn,
  title     = {{The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases}},
  author    = {Xu, Huji},
  journal   = {Nature Reviews Rheumatology},
  year      = {2025},
  volume    = {22},
  number    = {2},
  pages     = {78--79},
  doi       = {10.1038/s41584-025-01343-5},
  url       = {https://doi.org/10.1038/s41584-025-01343-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology

  • B-cell depletion
  • off-the-shelf therapy
  • autoimmune disease
  • chimeric antigen receptor
  • bispecific antibodies
  • B-cell depletion therapy

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Xu, H. (2025). The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases. Nature Reviews Rheumatology, 22(2), 78–79. https://doi.org/10.1038/s41584-025-01343-5

How many times has this paper been cited?

6 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Huji Xu.

What is the DOI of this paper?

10.1038/s41584-025-01343-5, permanently at https://doi.org/10.1038/s41584-025-01343-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.